Cardiology Division, William Beaumont Hospital, Royal Oak, MI.
Circ Cardiovasc Imaging. 2013 Sep;6(5):646-54. doi: 10.1161/CIRCIMAGING.112.000237. Epub 2013 Aug 7.
A best-practice intervention previously demonstrated significant dose reduction over a period of one year. We sought to evaluate whether this reduction would be incremental and sustained by promoting new scanner technology in the context of an ongoing quality improvement program during a 3-year period in a statewide registry of coronary computed tomography angiography.
In this prospective, controlled, nonrandomized study involving 11 901 patients at 15 Michigan centers participating in the Advanced Cardiovascular Imaging Consortium, radiation doses and image quality were compared between the following periods: control (May to June 2008) versus follow-up I (July 2008 to June 2009) and follow-up I versus follow-up II (July 2009 to April 2011). Intervention during these study periods included continuous education, feedback, and mandatory participation in this initiative. The median radiation dose remained unchanged from control to follow-up I: dose-length product of 697 (interquartile range, 407-1163) to 675 (interquartile range, 418-1146) mGy·cm (P=0.93). With the introduction of newer technology in follow-up I period, there was incremental 31% decrease during follow-up II to median dose-length product of 468 (interquartile range, 292-811) mGy·cm (P<0.0001). No significant change was noted in the percentage of diagnostic quality scans from follow-up I (92%) to follow-up II (92.7%).
Although ongoing application of a best-practice algorithm was associated with sustaining previously achieved targets, the use of newer scanner technology resulted in incremental radiation dose reduction in a statewide coronary computed tomography angiography registry without image quality degradation. Clinical Trial Registration- URL: http://www.clinicaltrials.gov. Unique identifier: NCT00640068.
先前的最佳实践干预措施在一年的时间内显著减少了剂量。我们试图评估在全州范围内的冠状动脉 CT 血管造影注册中心,在一项持续的质量改进计划中,推广新的扫描仪技术是否会在 3 年内增加并维持这种减少。
在这项涉及密歇根州 15 个中心的 11901 名患者的前瞻性、对照、非随机研究中,在以下时间段比较了辐射剂量和图像质量:对照组(2008 年 5 月至 6 月)与随访期 I(2008 年 7 月至 2009 年 6 月)以及随访期 I 与随访期 II(2009 年 7 月至 2011 年 4 月)。在这些研究期间,干预措施包括持续的教育、反馈和强制性参与这项倡议。辐射剂量中位数从对照组到随访期 I 没有变化:剂量长度乘积为 697(四分位距,407-1163)至 675(四分位距,418-1146)mGy·cm(P=0.93)。在随访期 I 期间引入了新的技术,随访期 II 中剂量长度乘积有 31%的增量减少至中位数 468(四分位距,292-811)mGy·cm(P<0.0001)。从随访期 I(92%)到随访期 II(92.7%),诊断质量扫描的百分比没有显著变化。
尽管持续应用最佳实践算法与维持先前的目标有关,但在全州范围内的冠状动脉 CT 血管造影注册中心,使用新的扫描仪技术在不降低图像质量的情况下,使辐射剂量进一步减少。
临床试验注册- URL:http://www.clinicaltrials.gov。唯一标识符:NCT00640068。